cancer vaccine (Jagiellonian/CITTRU)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Namecancer vaccine (Jagiellonian/CITTRU)

Drug Alias NameSalmonella-based vaccine (Jagiellonian University/CITTRU)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentVaccines > Application > Therapeutic vaccineBiologics > Antigen > Tumor antigen

Mechanisms of ActionCarcinoembryonic antigen related cell adhesion molecule 5 modulators

TargetsCarcinoembryonic antigen related cell adhesion molecule 5

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryPoland

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesJagiellonian University, Krakow

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesJagiellonian University, Krakow Institute of Technology Transfer and Innovation

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A